French Dx developer bioMérieux advanced in Q2, thanks to emerging markets

French diagnostics developer bioMérieux said its 2013 second quarter generated solid growth, thanks to solid expansion in emerging markets like China, India and Brazil. Keeping currency fluctuations in mind, the company said it booked €395 million ($515.4 million) in sales during the quarter, a 4% rise compared to last year. For the first half of the year, that sales number hit €754 million ($986.5 million), a 2% increase versus the same period in 2012. Item

Suggested Articles

U.K.-based surgery robot developer CMR Surgical has begun rolling out its Versius platform to the NHS, completing its first procedures in Europe.

The former Fierce 15 winner’s SuperMap program was cleared to guide electrophysiologists in the treatment of stable and transient arrhythmias.

Insulet announced new agreements with Abbott and Dexcom to connect their continuous glucose monitors with its upcoming tubeless, digital insulin pump,